|
|
|
OSUR Description — OraSure Technologies Inc.
Orasure Technologies is engaged in two segments Diagnostics, and Molecular Solutions. Co.'s Diagnostics business primarily consists of the development, manufacture, marketing and sale of simple, easy to use diagnostic products and specimen collection devices using its proprietary technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types. Co.'s Molecular Solutions products primarily consist of collection kits and services used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.
Company Name: |
OraSure Technologies Inc. |
Website: |
www.orasure.com |
Sector: |
Medical Instruments & Supplies |
Number of ETFs Holding OSUR: |
44 |
Total Market Value Held by ETFs: |
$97,940,931 |
Total Market Capitalization: |
$449,000,000 |
% of Market Cap. Held by ETFs: |
21.81% |
|
ETF |
OSUR Weight |
OSUR Amount |
IJR |
0.04% |
$30,423,003 |
VTI |
0.00% |
$13,204,182 |
IWM |
0.02% |
$10,781,414 |
VXF |
0.01% |
$6,774,938 |
IJT |
0.08% |
$4,438,095 |
SPSM |
0.04% |
$4,129,874 |
IWN |
0.03% |
$4,095,706 |
XSVM |
0.46% |
$3,621,736 |
SLYG |
0.08% |
$2,556,287 |
XHE |
0.86% |
$2,516,214 |
List of all 44 ETFs holding OSUR
» |
|
|
|
|
Hold (2.33 out of 4)
0th percentile
|
PARTNER NEWS:Wed, Jan 24, 7:40 AM, Zacks
Abbott (ABT) Q4 Earnings Match Estimates Abbott (ABT) delivered earnings and revenue surprises of 0% and 0.71%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Fri, Jan 19, 2:45 AM, Zacks
Zacks.com featured highlights Otter Tail, OraSure, BioMarin and Regeneron Otter Tail, OraSure, BioMarin and Regeneron have been highlighted in this Screen of The Week article.
|
|